Regular use of short-acting calcium channel blockers, such as Nifedipine, Amlodipine, and Verapamil, may facilitate the onset of pancreatic cancer in postmenopausal women.

​This study examined the correlation between the use of antihypertensive drugs and the risk of pancreatic cancer in women. A total of 145,551 women participated in this study and were assessed for their intake of antihypertensive medications and incidence of pancreatic cancer. 

Researchers observed that postmenopausal women who took short-acting calcium channel blockers (CCBs), such as Nifedipine, Amlodipine, and Verapamil for 3 or more years had 107% higher chances of acquiring pancreatic cancer. Evidence from this study show that the use of short-acting calcium channel blockers may fuel the development of pancreatic cancer in postmenopausal women.